Inventor · disambiguated record
Peter Sieling
Also filed as: SIELING PETER · SIELING PETER A · SIELING PETER ALLAN
9 granted patents·11 pending applications·41 citations·filing 1994–2025
83Inventor score
Top patents by PatentIndex Score
20 records- 0192US11298414B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2019·Granted Apr 12, 2022·6 cites·8 claims
- 0289US12350323B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2024·Granted Jul 8, 2025·0 cites·18 claims
- 0388US12329809B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0481US12290558B2SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogensIMMUNITYBIO INC·Filed 2023·Granted May 6, 2025·0 cites·11 claims
- 0581US10252269B2Methods of sorting activated T cells using three dimensional dielectrophoresisNANOCAV LLC·Filed 2017·Granted Apr 9, 2019·2 cites·25 claims
- 0681US2025262288A1Cellular Adjuvants for Viral InfectionNANTBIO INC·Filed 2025·Application pending·0 cites
- 0779US12220452B2Cellular adjuvants for viral infectionNANTBIO INC·Filed 2022·Granted Feb 11, 2025·0 cites·19 claims
- 0869US2025235530A1Anti COVID-19 Therapies targeting nucleocapsid and spike proteinsIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 0968US11857620B2Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirusIMMUNITYBIO INC·Filed 2021·Granted Jan 2, 2024·0 cites·11 claims
- 1068US2024358760A1Primary T-Cell ExpansionNANTBIO INC·Filed 2024·Application pending·0 cites
- 1167US5853737AMethod for inducing a CD1-restricted immune responseBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Dec 29, 1998·33 cites·60 claims
- 1260US2024327492A1Modified T Cell Receptors For The Prevention And Treatment Of Viral Infections And CancerNANTCELL INC·Filed 2022·Application pending·0 cites
- 1358US12016883B2Primary T-cell expansionNANTBIO INC·Filed 2020·Granted Jun 25, 2024·0 cites·9 claims
- 1453US2022170099A1Immunome profiling for engineering white blood cellsNANTOMICS LLC·Filed 2020·Application pending·0 cites
- 1553US2023236172A1T Cells That Respond To Patient NeoepitopesNANTCELL INC·Filed 2021·Application pending·0 cites
- 1652US2022187279A1Rapid t-cell assay for sars-cov-2IMMUNITYBIO INC·Filed 2021·Application pending·0 cites
- 1751US2024027462A1Arrayed peptide neoepitope generatorNANTBIO INC·Filed 2021·Application pending·0 cites
- 1848US2022347213A1Recombinant CD1-Restricted T Cells And MethodsNANTBIO INC·Filed 2019·Application pending·0 cites
- 1941US2020282037A1Bacterial vaccineNANTBIO INC·Filed 2018·Application pending·0 cites
- 2037US2016266125A1Methods of treating and predicting progression of cancer based on t cell subsetsWAYNE JOHN CANCER INST·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →